Ledger Run and ICE Global Consulting Strengthen Partnership to Enhance Clinical Trial Financial Management Services

Strengthened Partnerships in Clinical Trials

In a significant development within the healthcare and pharmaceutical sectors, Ledger Run, a prominent provider of clinical trial financial management solutions, has announced an expansion of its strategic partnership with ICE Global Consulting. This collaboration aims to refine the processes associated with clinical trial contracting and budget management, marking a pivotal shift in how these services are rendered.

The partnership between Ledger Run and ICE Global is designed to consolidate their respective strengths. While ICE Global continues to provide expertise in site contracting and budget management, Ledger Run is set to focus on enhancing its flagship product — the ClinRun platform. ClinRun is a comprehensive suite that integrates functionalities for budgeting, contracting, payments, and forecasting, thereby automating procedures and mitigating errors through advanced technology.

This new phase of collaboration not only seeks to improve the customer experience for all stakeholders involved but also aims to bolster operational efficiencies through intelligent automation. The merging of ICE Global's seasoned clinical contracting team with Ledger Run's cutting-edge, AI-powered financial platform technology promises a seamless transaction process for clients. As stated by Brooke Millman-Ice, CEO of ICE Global Consulting, this partnership will offer clients direct access to a globally-experienced team and strengthen their contracting services.

Advancements in Technology

Ledger Run is prioritizing continuous investment in research and development. Recent updates to the ClinRun platform have incorporated sophisticated automation features that enhance the speed and accuracy of payment processing. This includes an intelligent automation system that takes over low-value payment processing tasks, which historically have been manual and time-consuming. Patrick Mizer, Chief Technology Officer at Ledger Run, emphasized the necessity for automation in areas that detract focus from strategic tasks critical to clinical research.

Furthermore, the partnership will significantly enhance site experience during clinical trials, addressing a growing demand among sponsors and contract research organizations (CROs) for faster and clearer payment processes. As the competition between sites intensifies—currently standing at approximately four trials available per site—streamlined payment operations are becoming increasingly vital for attracting capable research sites.

Hightower Clinical's CEO, Brad Hightower, echoed this sentiment, noting that sponsors prioritizing prompt payments and financial transparency tend to become preferred partners for research sites. The strategies discussed during recent industry conferences highlight a shift towards making payment efficiency a key metric in establishing fruitful collaborations.

Looking Ahead

As the partnership evolves, both Ledger Run and ICE Global are optimistic about the capabilities they can offer their clients. The integration of experienced professionals at ICE Global with the technology prowess of Ledger Run is a strategic move aimed at addressing the intricate demands of modern clinical research. By offering a suite of contracting and legal support solutions, ICE Global further enhances the services available to Ledger Run’s clients, paving the way for improved efficiency across the clinical development lifecycle.

With the clinical research industry anticipating increasing complexity in contracting and budgeting, Ledger Run's commitment to enhancing the ClinRun platform will serve as a cornerstone in navigating these changes. John Chinnici, CEO of Ledger Run, expressed confidence in the new direction of their collaboration, highlighting that the synergy between their technological advancements and ICE Global's domain expertise will propel the industry forward.

In sum, this expanded partnership between Ledger Run and ICE Global Consulting heralds a new chapter in clinical trial management, with a strong focus on automation and efficiency that promises to benefit research sponsors and sites alike. As both companies prepare to leverage their expertise for future growth, the industry can expect to see transformative changes in how clinical trials are conducted, ultimately improving outcomes for all stakeholders involved.